| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |